Development and validation of a questionnaire for assessing androgen deficiency in women (FAD - Female Androgen Deficiency) of reproductive age


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Relevance: The early manifestations of androgen deficiency begin in women after the age of 35, particularly in infertile patients with diminished ovarian reserve (DOR). Their detection can be used in clinical practice to assess the degree of androgen deficiency and to predict possible outcomes of assisted reproductive technology (ART) (IVF/ICSI) programs. Objective: To develop and validate a Female Androgen Deficiency (FAD) questionnaire for assessing androgen def iciency in infertility women for f urther use in clin ical practice. Materials and methods: We developed the FAD questionnaire in accordance with international and Russian standards and tested it with a focus group of women with presumed androgen deficiency including infertile women with diminished ovarian reserve. After that we assessed the results of psychometric testing including reliability, validity and sensitivity of the developed questionnaire. Results: The results of FAD testing with the participation of patients and expert clinical opinion confirmed the acceptability of the FAD questionnaire, its compliance with the environment, and high indicators of content and external validity. The stable structure of the instrument was shown, indicating satisfactory construct validity of the questionnaire. The a-Cronbach's coefficient was equal to 0.837, indicating the internal consistency of the FAD questionnaire. An analysis of the correlations between the total FAD score and the number of symptoms in infertile women with DOR revealed a statistically significant strong negative relationship (r=-0.76; p<0.001), which reflects good criterion validity. The factor analysis showed the adequacy of the questionnaire's factor structure according to the relationships between variables and its stable construct validity. The total quality of life score on the questionnaire was lower in healthy women than in women with DOR [31.7(6.2) vs 18.4 (4.1)], demonstrating satisfactory discriminant validity of the questionnaire. The correlation analysis of the FAD and FSFI showed satisfactory convergent validity of the FAD questionnaire. Conclusion: The study results testify to the reliability, validity, and sensitivity of the FAD questionnaire and its use for both clinical practice and for scientific purposes in obstetrics and gynecology, in particular, gynecological endocrinology and reproductive medicine.

Full Text

Restricted Access

About the authors

Andrey A. Chausov

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: a_chausov@oparina4.ru
Head of the Information and Analytical Center of the Department of Regional Cooperation and Integration

Alla A. Gavisova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: gavialla@yandex.ru
PhD, Senior Researcher at the 1st Gynecological Department

Nataliya V. Dolgushina

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: n_dolgushina@oparina4.ru
Dr. Med. Sci., Professor, Deputy Director - Head of the Department for Scientific Projects Administration

Tatiana A. Nazarenko

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Email: t_nazarenko@oparina4.ru
Dr. Med. Sci., Professor, Director of Institute of Reproductive Medicine

Zhanna R. Gardanova

Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation; N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: zanna7777@inbox.ru
Dr. Med. Sc., Professor, Senior Researcher, V.I. Kulakov NMRC for OG&P

References

  1. Bachmann G., Bancroft J., Braunstein G., Burger H., Davis S., Dennerstein L. et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil. Steril. 2002; 77(4): 660-5. https://dx.doi.org/10.1016/s0015-0282(02)02969-2.
  2. Butler L., Santoro N. The reproductive endocrinology of the menopausal transition. Steroids. 2011; 76(7): 627-35. https://dx.doi.org/10.1016/j.steroids.2011.02.026.
  3. Davison S.L., Bell R. Androgen physiology. Semin. Reprod. Med. 2006; 24(2): 71-7. https://dx.doi.org/10.1055/s-2006-939565.
  4. Dennerstein L., Randolph J., Taffe J., Dudley E., Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil. Steril. 2002; 77(Suppl. 4): S42-8. https://dx.doi.org/10.1016/s0015-0282(02)03001-7.
  5. Roney J.R., Simmons Z.L. Hormonal predictors of sexual motivation in natural menstrual cycles. Horm. Behav. 2013; 63(4): 636-45. https://dx.doi.org/10.1016/j.yhbeh.2013.02.013.
  6. Bramen J.E., Hranilovich J.A., Dahl R.E., Chen J., Rosso C., Forbes E.E. et al. Sex matters during adolescence: testosterone-related cortical thickness maturation differs between boys and girls. PLoS One. 2012; 7(3): e33850. https://dx.doi.org/10.1371/journal.pone.0033850.
  7. Cappelletti M., Wallen K. Increasing women's sexual desire: the comparative effectiveness of estrogens and androgens. Horm. Behav. 2016; 78: 178-93. https://dx.doi.org/10.1016/j.yhbeh.2015.11.003.
  8. Nastri C., Lara L.A., Ferriani R.A., Rosa-E-Silva A.C., Figueiredo J.B., Martins W.P. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst. Rev. 2013; (6): CD009672. https://dx.doi.org/10.1002/14651858.CD009672.pub2.
  9. Davis S.R., Goldstat R., Pap alia M.A., Shah S., Kulkarni J., Donath S., Bell R.J. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause. 2006; 13(1): 37-45. https://dx.doi.org/10.1097/01.gme.0000168061.32917.83.
  10. Graziottin A. The biological basis of female sexuality. Int. Clin. Psychopharmacol. 1998; 13(Suppl. 6): S15-22. https://dx.doi.org/10.1097/00004850-199807006-00004.
  11. Heinemann L.A., Saad F., Zimmermann T., Novak A., My on E., Badia X. et al. The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. Health Qual. Life Outcomes. 2003; 1: 15. https://dx.doi.org/10.1186/1477-7525-1-15.
  12. Heinemann L.A.J., Zimmermann T., Vermeulen A., Thiel C. A New ‘Aging Male’s Symptoms’ (AMS) rating scale. Aging Male. 1999; 2(2): 105-14. http://dx.doi.org/10.3109/13685539909003173.
  13. Davis S.R. The Kupperman Index undressed. Maturitas. 2019; 26: 90-1. https://dx.doi.org/10.1016/j.maturitas.2019.04.219.
  14. Rosen R., Brown C., Heim an J., Leiblum S., Meston C., Shabsigh R. et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J. Sex Marital Ther. 2000; 26(2): 191-208. https://dx.doi.org/10.1080/009262300278597.
  15. Стеняева Н.Н., Хритинин Д.Ф., Чаусов А.А. Гинекологические заболевания как предикторы женской сексуальной дисфункции. Гинекология. 2021; 23(2): 149-54. https://dx.doi.org/10.26442/20795696.202L2.200784.
  16. Heinemann L.A., Thiel C., Assmann A., Zimmermann T., Hummel W., Vermeulen A. Sex differences in 'climacteric symptoms' with increasing age? A hypothesis-generating analysis of cross-sectional population surveys. Aging Male. 2000; 3(3): 124-31. https://dx.doi.org/10.1080/13685530008500334.
  17. Poletti A., Martini L. Androgen-activating enzymes in the central nervous system. J. Steroid Biochem. Mol. Biol. 1999; 69(1-6): 117-22. https://dx.doi.org/10.1016/s0960-0760(98)00150-2.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies